Press Releases

Creative Biogene: A Premier Partner in the Exploration of Pathogenesis of Mitochondrial-Associated Diseases

Creative Biogene has become the premier partner to cooperate in the exploration of the pathogenesis of mitochondrial-associated diseases.

Pronalyse Launches Antibody Drug Conjugates (ADCs) Characterization Service for Drug Discovery

Pronalyse, a new division of Creative Proteomics, is an integrated CRO company with rich experience in providing drug development services for over 10 years. Creative Proteomics Pronalyse recently announced the launch of antibody-drug conjugates (ADCs) characterization service to ensure the safety and effectiveness of ADCs drugs.

Lipidomics Bioinformation Analysis Now Available by Creative Proteomics’s Lipidomics Platform

As a division of Creative Proteomics, Lipidomics is dedicated to providing cutting-edge mass spectrometry (MS)-based lipidomics services for biomedical research institutions, biotechnological and pharmaceutical companies. The company has recently announced the launch of fully-developed lipidomics bioinformation analysis service to screen differential lipid molecules and analyze their pathways, revealing the physiological mechanism of their changes.

Creative Proteomics Metabolomics Expands Service Offering with the Launch of Microbial Metabolomics Solutions

Metabolomics, a division of Creative Proteomics, is dedicated to providing cutting-edge LC-MS based metabolomics services for biomedical research institutions, biotechnology and pharmaceutical companies. With deep industry and business process expertise and a good reputation in providing contract services specialized for metabolomics, Creative Proteomics Metabolomics announced the launch of microbial metabolomics service to promote a comprehensive understanding of microbial physiology.

VERICHEM NOW OFFERS MATRIX PLUS ™ CHEMISTRY REFERENCE MATERIALS FOR CALIBRATION VERIFICATION APPLICATIONS

VERICHEM offers clinical laboratories their liquid stable and ready-to-use MATRIX PLUS™ Chemistry Reference Materials which are expressly designed for the calibration and calibration verification of chemistry assays and to support overall system QC and CLIA compliance.

Creative Bioarray Develops Cell Immortalization Kits and Immortalized Human Cells to Support Immortalized Cell Research

DDA platform Provides In Vitro Skin Absorption Test to Support The Studies in Comestics

Acroscell Releases Voltage-gated Potassium Channels to Accelerate The Development of Drug Development

Qvirus Platform Offers Custom Baculovirus Production to Accelerate High-level Gene Expression

Creative Biogene Launches A Large Panel of Genome Editing Services to Accelerate Bioprocess of Drug Development

Microbialtec Established A Mature Platform for Escherichia Coli Cultivation to Accelerate Microbial Isolation and Culture

CD Formulation Offers Customized Synthesis to Meet the Demand for Lipid Excipients

As a New York-based CRO company, CD Formulation has keenly observed that the demand for tailored pharmaceutical excipients is on the rise, especially over the past decade, as each formulation project may need unique excipients. In response to such a market trend, the management of CD Formulation earlier this month announces to offer customized synthesis for lipid excipients, which are used in lipid-based dosage forms for the enhancement of drug absorption or delivery.

Nanomaterial News Update: Alfa Chemistry Upgrades Its Nanoprism Product Line

Medix Biochemica announces the launch of its refreshed, and expanding, brand

Medix Biochemica has announced the launch of its refreshed and expanding brand to reflect both the exciting improvements to its offering as a result of recent acquisitions and its ongoing commitment to the in vitro diagnostics (IVD) industry.

WuXi STA Passes the First EMA Drug Product Pre-Approval Inspection at its Wuxi City Site

Arctoris and Evariste Technologies form a Joint Venture to Identify Novel Small Molecule cMET Inhibitors for Non-Small Cell Lung Cancer

Arctoris and Evariste Technologies have announced they have formed a joint venture to identify novel small molecule kinase inhibitors for treatment of patients with Non-Small Cell Lung Cancer (NSCLC).

Lonza Leads Market with Large and HLA-Typed CD34+ Cell Lots for Efficient Humanized Mouse Model Development

Lonza has expanded its renowned human stem cell offerings to provide human cord blood CD34+ hematopoietic stem cells (CB-CD34+ HSCs) in large batch sizes, meeting a critical and rapidly expanding market need

New, Innovative GC and GC-MS Product Portfolio Enables Greater Uptime and Efficiency

Thermo Fisher Scientific today announced the launch of its new innovative GC and GC-MS product portfolio designed to enhance usability, productivity and profitability.

Alfa Chemistry Announces Completion of Building a Sub-website for Polymer Stabilizers

CD Formulation Announces Ability to Achieve Solubility Improvement and Bioavailability Enhancement for Drug Formulation Projects